Host Innate Immunity Against Hepatitis Viruses and Viral Immune Evasion

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2021 Nov 22

PMID 34803956

Citations 6

Authors

Chonghui Xu

Jizheng Chen

Xinwen Chen

Affiliations

Soon will be listed here.

Abstract

Hepatitis viruses are primary causative agents of hepatitis and represent a major source of public health problems in the world. The host innate immune system forms the first line of defense against hepatitis viruses. Hepatitis viruses are sensed by specific pathogen recognition receptors (PRRs) that subsequently trigger the innate immune response and interferon (IFN) production. However, hepatitis viruses evade host immune surveillance via multiple strategies, which help compromise the innate immune response and create a favorable environment for viral replication. Therefore, this article reviews published findings regarding host innate immune sensing and response against hepatitis viruses. Furthermore, we also focus on how hepatitis viruses abrogate the antiviral effects of the host innate immune system.

Citing Articles

Limited impact of hepatitis A virus 3C protease-mediated cleavage on the functions of NEMO in human hepatocytes.

Huang H, Colasanti O, Li T, Lohmann V J Virol. 2025; 99(2):e0226424.

PMID: 39853114 PMC: 11852894. DOI: 10.1128/jvi.02264-24.

Viral Hepatitis: Host Immune Interaction, Pathogenesis and New Therapeutic Strategies.

Quirino A, Marascio N, Branda F, Ciccozzi A, Romano C, Locci C Pathogens. 2024; 13(9).

PMID: 39338957 PMC: 11435051. DOI: 10.3390/pathogens13090766.

Hepatocytes and the art of killing Plasmodium softly.

Marques-da-Silva C, Schmidt-Silva C, Kurup S Trends Parasitol. 2024; 40(6):466-476.

PMID: 38714463 PMC: 11156546. DOI: 10.1016/j.pt.2024.04.004.

Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.

Soleiman-Meigooni S, Yarahmadi A, Kheirkhah A, Afkhami H Front Immunol. 2024; 15:1363996.

PMID: 38545106 PMC: 10965641. DOI: 10.3389/fimmu.2024.1363996.

Beyond schistosomiasis: unraveling co-infections and altered immunity.

Perera D, Koger-Pease C, Paulini K, Daoudi M, Ndao M Clin Microbiol Rev. 2024; 37(1):e0009823.

PMID: 38319102 PMC: 10938899. DOI: 10.1128/cmr.00098-23.

References

Reizis B, Bunin A, Ghosh H, Lewis K, Sisirak V . Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol. 2011; 29:163-83. PMC: 4160806. DOI: 10.1146/annurev-immunol-031210-101345. View

Howell J, Angus P, Gow P, Visvanathan K . Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment. J Gastroenterol Hepatol. 2013; 28(5):766-76. DOI: 10.1111/jgh.12170. View

Surjit M, Varshney B, Lal S . The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells. BMC Biochem. 2012; 13:7. PMC: 3506457. DOI: 10.1186/1471-2091-13-7. View

Yi Z, Chen J, Kozlowski M, Yuan Z . Innate detection of hepatitis B and C virus and viral inhibition of the response. Cell Microbiol. 2015; 17(9):1295-303. DOI: 10.1111/cmi.12489. View

Ding Q, Cao X, Lu J, Huang B, Liu Y, Kato N . Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J Hepatol. 2013; 59(1):52-8. DOI: 10.1016/j.jhep.2013.03.019. View

Lei Q, Li L, Zhang S, Li T, Zhang X, Ding X . HEV ORF3 downregulates TLR7 to inhibit the generation of type I interferon via impairment of multiple signaling pathways. Sci Rep. 2018; 8(1):8585. PMC: 5988675. DOI: 10.1038/s41598-018-26975-4. View

Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A . The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol. 2011; 55(4):762-9. DOI: 10.1016/j.jhep.2010.12.042. View

Cao X, Ding Q, Lu J, Tao W, Huang B, Zhao Y . MDA5 plays a critical role in interferon response during hepatitis C virus infection. J Hepatol. 2014; 62(4):771-8. DOI: 10.1016/j.jhep.2014.11.007. View

Ayoobi F, Hassanshahi G, Zainodini N, Khorramdelazad H, Arababadi M, Kennedy D . Reduced expression of TRIF in chronic HBV infected Iranian patients. Clin Res Hepatol Gastroenterol. 2013; 37(5):491-5. DOI: 10.1016/j.clinre.2012.11.005. View

10.

Huang F, Yang C, Yu W, Bi Y, Long F, Wang J . Hepatitis E virus infection activates signal regulator protein α to down-regulate type I interferon. Immunol Res. 2015; 64(1):115-22. DOI: 10.1007/s12026-015-8729-y. View

11.

Isogawa M, Robek M, Furuichi Y, Chisari F . Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol. 2005; 79(11):7269-72. PMC: 1112123. DOI: 10.1128/JVI.79.11.7269-7272.2005. View

12.

Koyama S, Ishii K, Coban C, Akira S . Innate immune response to viral infection. Cytokine. 2008; 43(3):336-41. DOI: 10.1016/j.cyto.2008.07.009. View

13.

Feng Z, Lemon S . Innate Immunity to Enteric Hepatitis Viruses. Cold Spring Harb Perspect Med. 2018; 9(3). PMC: 6396338. DOI: 10.1101/cshperspect.a033464. View

14.

Liang Y, Cao X, Ding Q, Zhao Y, He Z, Zhong J . Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway. PLoS Pathog. 2018; 14(5):e1007075. PMC: 5983870. DOI: 10.1371/journal.ppat.1007075. View

15.

Xu J, Wu F, Tian D, Wang J, Zheng Z, Xia N . Open reading frame 3 of genotype 1 hepatitis E virus inhibits nuclear factor-κappa B signaling induced by tumor necrosis factor-α in human A549 lung epithelial cells. PLoS One. 2014; 9(6):e100787. PMC: 4069097. DOI: 10.1371/journal.pone.0100787. View

16.

Suarez-Amaran L, Usai C, di Scala M, Godoy C, Ni Y, Hommel M . A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction. J Hepatol. 2017; 67(4):669-679. DOI: 10.1016/j.jhep.2017.05.010. View

17.

Yao Y, Shen Y, Shao H, Liu Y, Ji Y, Du G . Polymorphisms of RIG-I-like receptor influence HBV clearance in Chinese Han population. J Med Virol. 2021; 93(8):4957-4965. DOI: 10.1002/jmv.26969. View

18.

Sepehri Z, Kiani Z, Alavian S, Arababadi M, Kennedy D . The link between TLR7 signaling and hepatitis B virus infection. Life Sci. 2016; 158:63-9. DOI: 10.1016/j.lfs.2016.06.026. View

19.

Xiong W, Wang X, Liu X, Xiang L, Zheng L, Yuan Z . Interferon-inducible MyD88 protein inhibits hepatitis B virus replication. Virology. 2004; 319(2):306-14. DOI: 10.1016/j.virol.2003.11.005. View

20.

Feng Z, Li Y, McKnight K, Hensley L, Lanford R, Walker C . Human pDCs preferentially sense enveloped hepatitis A virions. J Clin Invest. 2014; 125(1):169-76. PMC: 4382264. DOI: 10.1172/JCI77527. View